Arcutis Biotherapeutics, Inc.
ARQT
Κατάταξη σε μετοχές
#4071
Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to... Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds. Among these is ARQ-154, a roflumilast foam applied topically, aimed at seborrheic dermatitis and scalp psoriasis. Furthermore, ARQ-252, a topical selective Janus kinase type 1 (JAK1) inhibitor, is under investigation for hand eczema and vitiligo. ARQ-255, a variation of ARQ-252 designed for deeper dermal absorption, is being explored for alopecia areata. Established in 2016, the company was initially named Arcutis, Inc. before changing to Arcutis Biotherapeutics, Inc. in October 2019. Its corporate headquarters are situated in Westlake Village, California.
Τιμή μετοχής
$32.17
Κεφαλαιοποίηση
$4.04B
Αλλαγή (1 ημέρα)
11.62%
Αλλαγή (1 έτος)
54.06%
Χώρα
US
Εμπόριο Arcutis Biotherapeutics, Inc. (ARQT)
Κατηγορία
Healthcare
EPS για Arcutis Biotherapeutics, Inc. (ARQT)
EPS στις June 2026 TTM: $0.22
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή της μετοχής της Arcutis Biotherapeutics, Inc., το τρέχον EPS της εταιρείας (TTM) είναι $0.22. Στο τέλος του 2023, η εταιρεία είχε EPS $-3.78, μείωση σε σύγκριση με το EPS του 2022 που ήταν $-5.66.
Ιστορικό EPS της Arcutis Biotherapeutics, Inc. από 2017 έως 2026
EPS στο τέλος κάθε έτους
| Έτος | EPS | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $0.22 | -118.97% |
| 2024 | $-1.16 | -69.31% |
| 2023 | $-3.78 | -33.22% |
| 2022 | $-5.66 | 35.73% |
| 2021 | $-4.17 | 9.74% |
| 2020 | $-3.80 | 245.45% |
| 2019 | $-1.10 | 107.55% |
| 2018 | $-0.53 | -88.75% |
| 2017 | $-4.71 | 0.00% |
EPS για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | EPS | Διαφορά EPS | Χώρα |
|---|---|---|---|
| $17.32 | 7,772.73% |
US
|
|
| $-7.98 | -3,727.27% |
US
|
|
| $-5.29 | -2,504.55% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | 12,509.09% |
NL
|
